Rankings
▼
Calendar
VCEL Q2 2021 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$40M
+97.5% YoY
Gross Profit
$27M
68.1% margin
Operating Income
-$4M
-9.4% margin
Net Income
-$4M
-9.6% margin
EPS (Diluted)
$-0.08
QoQ Revenue Growth
+14.3%
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
$3M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$222M
Total Liabilities
$71M
Stockholders' Equity
$151M
Cash & Equivalents
$52M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$40M
$20M
+97.5%
Gross Profit
$27M
$11M
+137.0%
Operating Income
-$4M
-$8M
+55.4%
Net Income
-$4M
-$8M
+54.2%
Revenue Segments
MACI Implants and Kits, and Epicel
$39M
100%
← FY 2021
All Quarters
Q3 2021 →